The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it buy, with a mean price target of $32.
Innovex International, Inc. INVX
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Innovex International, Inc.
read at $25.78
Innovex International, Inc. holds its Distribution at $25.78.
- PHPhase · the trend structure carries the Distribution label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price | $25.78 |
| Valuation | 34.37 trailing · 13.20 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | N/A |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | -0.60% |
| Profit margin | 5.31% |
| Debt to equity | 7.39 |
| Analyst consensus | None · 5 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Oil tools maker stuck in a flat cycle
Picture an oilfield supplier whose kit only earns when drillers are flush. Innovex sits right there, with revenue already slipping one percent and margins stuck at five percent. The forward multiple of 13 times looks modest until you remember this is a cyclical business where peak earnings often arrive just before the next downturn. Fair value sits level with the current price, leaving no margin of safety and no reason to step in.
The low return on equity of five percent tells the same story. Capital is not compounding, the moat is unclear, and growth has turned negative. In equipment and services tied to rig counts, a cheap multiple is usually a warning rather than a bargain, especially when the next oil-price swing can wipe out several years of thin profits.
Ethics clear the screen, yet the numbers still fail on every other test. Five analysts see upside to thirty-five dollars, but that target rests on assumptions that rarely hold through a full cycle. We pass. Analysis, not advice.
| Forward P/E | 13.2x reasonably valued |
| Trailing P/E | 34.4x a premium valuation |
| Revenue growth | -0.6% revenue is shrinking |
| Profit margin | 5.3% thin but positive margins |
| Return on equity | 5.2% a modest return on shareholder capital |
| Debt to equity | 0.07 minimal debt — a conservative balance sheet |
| Current ratio | 5.10 comfortably covers its short-term bills |
| Market cap | $1.8B |
| Employees | 2,160 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in INVX's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
INVX trades on the NYSE. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it buy, with a mean price target of $32.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $27.06 | +6.7% | · | $1,067 | +6.7% |
| 2 months | $26.51 | +8.9% | · | $1,089 | +8.9% |
| 3 months | $24.13 | +19.7% | · | $1,197 | +19.7% |
| 6 months | $23.04 | +25.4% | · | $1,254 | +25.4% |
| 1 year | $16.17 | +78.6% | · | $1,786 | +78.6% |
| 2 years | $18.07 | +59.8% | · | $1,598 | +59.8% |
| 3 years | $25.30 | +14.2% | · | $1,142 | +14.2% |
| 5 years | $37.75 | -23.5% | · | $765 | -23.5% |
Historical returns from market close data. Past performance does not guarantee future results.